1072102-01-2

Basic information

• Product Name: (3S,6R)-4-benzyl-3,6-dimethylpiperazine-2,5-dione
• Synonyms: (3S,6R)-4-benzyl-3,6-dimethylpiperazine-2,5-dione
• CAS NO: 1072102-01-2
• Molecular Weight: 232.282
• Mol File: 1072102-01-2.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: (3S,6R)-4-benzyl-3,6-dimethylpiperazine-2,5-dione(CAS DataBase Reference)
• NIST Chemistry Reference: (3S,6R)-4-benzyl-3,6-dimethylpiperazine-2,5-dione(1072102-01-2)
• EPA Substance Registry System: (3S,6R)-4-benzyl-3,6-dimethylpiperazine-2,5-dione(1072102-01-2)

Safety Data

• Hazardous Substances Data: 1072102-01-2(Hazardous Substances Data)

Upstream product

• 159999-80-1 N-benzyl-N-Boc-L-alanine 
• 1072101-99-5 C₁₉H₂₈N₂O₅ 
• 1254043-76-9 (S)-methyl 2-{(R)-N-benzyl-2-[(tert-butoxycarbonyl)amino]propane amide}propanoate 
• 1072102-00-1 C₁₄H₂₀N₂O₃*ClH 

Downstream Products

• 431062-00-9 4-benzyl-2R,5S-dimethyl-piperazine-1-carboxylic acid tert-butyl ester 
• 260254-80-6 trans-2R,5S-dimethyl-4-benzyl-piperazine 
• 1046788-31-1 4-(((2R,5S)-4-benzyl-2,5-dimethylpiperazin-1-yl)methyl)tetrahydro-2H-pyran-4-ol 
• 216532-43-3 (-)-(2R,5S)-1-benzyl-2,5-dimethylpiperazine 

Relevant articles and documents

Asymmetric synthesis of 3,4,6-trisubstituted 2,5-diketopiperazines by using dynamic kinetic resolution of α-bromo tertiary acetamides

A new and efficient method for the asymmetric synthesis of 3,4,6-trisubstituted 2,5-diketopiperazines has been developed. The dynamic kinetic resolution of L-amino-acid-derived α-bromo tertiary amides in the nucleophilic substitution reaction with p-anisi

3-AMIDO-PYRROLO[3,4-C]PYRAZOLE-5(1H, 4H,6H) CARBALDEHYDE DERIVATIVES AS INHIBITORS OF PROTEIN KINASE C

The present invention relates to compounds and pharmaceutically acceptable salts of Formula (I): wherein X, R1, R2, R3, R4, R5, R6, R7, and R8 are as defined above. The invention further relates to pharmaceutical compositions comprising the compounds and pharmaceutically acceptable salts and to methods of treating diabetes mellitus and its complications (including in particular diabetic retinopathy, nephropathy or neuropathy), cancer, ischemia, inflammation, central nervous system disorders, cardiovascular disease, Alzheimer's disease and dermatological disease pression, viral diseases, inflammatory disorders, or diseases in which the liver is a target organ